Sitemap

About us Expand / Hide

• Institute in numbers

• Organization structure

• Research networks

• Director

• Advisory board

Research areas

Departments Expand / Hide

• Leipzig location Expand / Hide

  • Department of GMP Cell and Gene Therapy Expand / Hide

    • Projects

    • Equipment

    • Publications

  • Department of Cell and Gene Therapy Development Expand / Hide

    • Projects

    • Publications

    • Cell and Molecular Biology

    • NK Cell Technologies

    • In Vivo Models

    • GMP Development

    • GMP Biopharmaceuticals

    • Automated production technologies for mRNA-based drugs

    • QualiBioPharma

  • Department of Preclinical Development and Validation Expand / Hide

    • Publications of the department

    • Projects of the department

    • Expert reports

    • Scientific staff

  • Department of Vaccines and Infection Models Expand / Hide

    • Vaccine Technologies

    • Preclinical Validation

    • Antimicrobial Biotechnology

  • Department of Diagnostics Expand / Hide

    • CardiOmics

    • Ligand Development

    • Experimental Imaging

    • MicroDiagnostics

    • DNA Nanodevices

    • Next-Generation Diagnostics

    • Bioinformatics

    • Biological Material Analytics

    • SaxoCOV

• Halle (Saale) location Expand / Hide

  • Department of Drug Design and Target Validation Expand / Hide

    • Projects

    • Drugs and structural biology

    • Analytics

    • Pharmacology

    • Antibody technologies

• Rostock location Expand / Hide

  • Department of Extracorporeal Therapy Systems Expand / Hide

    • Projects

    • Expertise

    • Partners

    • Publications and Patents

    • ASSESS-MED

• Würzburg location Expand / Hide

  • Department of Cellular Immunotherapy Expand / Hide

    • Projects

• Potsdam-Golm location

• SaxoCell

Central facilities Expand / Hide

• RIBOLUTION Biomarker Center

• Center for Experimental Medicine Expand / Hide

  • Preclinical models

  • Animal experiments and animal welfare at Fraunhofer IZI Expand / Hide

    • Example projects

    • Animal experiments

    • Animal husbandry

    • Animal welfare

• GLP Test Facility Expand / Hide

  • Studies

  • Publications

• S3 safety laboratory Expand / Hide

  • Publications

  • Reference projects

• Advanced Analytics Technology Platform Expand / Hide

  • Flow cytometry

  • Chromatography and Mass Spectrometry

  • Sequencing

  • Bioinformatics

  • Microscopy

  • Binding analytics

• CIMD Biomaterial Bank

Press / media Expand / Hide

• News and press releases Expand / Hide

  • Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology

  • 3rd Fraunhofer Life Science Symposium: Ischemia and Regeneration

  • DASGIP and Fraunhofer IZI cooperate in 1.1 Million Euro Stem Cell Project

  • Key note lectures at the 3rd Fraunhofer Life Science Symposium in Leipzig

  • Final chance for abstract submission for the 3rd Fraunhofer Life Science Symposium

  • 3rd Fraunhofer Life Science Symposium extends submission of abstracts

  • Programme for the 3rd Fraunhofer Life Science Symposium is online

  • Scientific Highlights of the 3rd Fraunhofer Life Science Symposium

  • Stroke and Cardiac infarction: New approaches and potential for regeneration

  • Submit an Abstract and join the World Conference on Regenerative Medicine in Leipzig

  • Veterinary scientists join World Conference on Regenerative Medicine

  • International elite of regenerative medicine in October in Leipzig

  • Business Plan Competition at the World Conference on Regenerative Medicine organized by HHL

  • Rapid Prototyping in Regenerative Medicine at the 4th Fraunhofer Life Science Symposium

  • Canadian company expands to Leipzig

  • Stem cell bank InnovaStem GmbH cooperates with Fraunhofer IZI Leipzig

  • World Conference on Regenerative Medicine ends with record attendance

  • Fraunhofer IZI receives GMP-manufacturing authorisation for autologous stem cells derived from bone marrow

  • Fraunhofer IZI receives Statement of GLP Compliance for immunotoxicologic testing

  • Prima BioMed Ltd enters agreement with Fraunhofer Institute for Cell Therapy and Immunology in Leipzig to produce cancer vaccine

  • Manufacturing license for separation of stem cells from cord blood

  • Europe-wide project for the fight against West-Nile-Fever

  • World Conference on Regenerative Medicine in Leipzig: Registration and abstract submission now open

  • Innovative therapy method for the treatment of brain tumors

  • World Conference on Regenerative Medicine strengthens international relations with California

  • Novel method for treating ovarian cancer

  • Fraunhofer IZI recieved manufacuring authorization for tumor vaccine CVac™

  • Experts from all over the world exchanged their latest results within the field of regenerative medicine

  • DCVax® milestones reached

  • Neuroscientists discuss latest research results in Potsdam

  • Fraunhofer IZI received manufacturing authorization for DCVax®-L Brain

  • Fraunhofer Institute for Cell Therapy and Immunology consolidates cooperation with Canadian top university

  • World Conference on Regenerative Medicine in Leipzig: Registration and abstract submission now open

  • Innovative therapy method in ovarian cancer treatment – Clinical study launched

  • Chonnam National University Hospital Hwasun (CNUHH) and Fraunhofer Institute for Cell Therapy and Immunology IZI intensify collaboration

  • World Conference on Regenerative Medicine: Exchange program with partner country Canada – Apply now!

  • World Conference on Regenerative Medicine: Last chance for abstract submission

  • Analytik Jena AG granted approval for two new procedures to detect PRRS virus which were developed together with the Fraunhofer Institute for Cell Therapy and Immunology

  • Development of a new therapeutic procedure for the treatment of acute stroke

  • New test platform to detect sexually transmitted pathogens

  • PolyQuant and Fraunhofer IZI develop new codonprecise peptide library

  • World Conference on Regenerative Medicine: International experts discuss latest advances in regenerative medicine

  • Opening of the World Conference on Regenerative Medicine

  • Around 1000 leading scientists discussed latest research findings at the World Conference on Regenerative Medicine

  • Fraunhofer IZI and McMaster University (Canada) Sign Memorandum of Agreement

  • Development of a new diagnostic platform for improved cancer diagnostics

  • New findings in the field of neuroscience to be discussed in Magdeburg

  • Fraunhofer IZI granted manufacturing authorization for second GMP facility

  • Fraunhofer Life Science Symposium: call for abstracts!

  • Northwest Biotherapeutics receives authorisation for new cancer therapy in accordance with §4b German Medical Act

  • Fraunhofer IZI broadens expertise with new division in Potsdam-Golm

  • Junk DNA not as worthless as once thought

  • Fraunhofer algae en route to ISS

  • Saxon Fraunhofer Institutes set up joint bio-nano application laboratory

  • Experts discuss new developments in the field of stem cell research and cell therapy

  • Project LEGATEST wins Innovation Award

  • Fraunhofer Institute for Cell Therapy and Immunology launches CART collaboration

  • Establishment of a new Fraunhofer Project Centre at McMaster Innovation Park

  • Fraunhofer IZI researchers in Nice to discuss perspectives in the treatment of neurodegenerative diseases

  • World Conference on Regenerative Medicine 2015 in Leipzig: Registration and Abstract Submission now open

  • Fraunhofer Institute for Cell Therapy and Immunology Celebrates Ten Year Anniversary in Leipzig

  • Fraunhofer IZI and University Clinic of the Martin-Luther University in Halle to carry out joint research into the role of endogenous retroviruses in human diseases

  • World Conference on Regenerative Medicine 2015 in Leipzig: Abstract Submission has been extended to 24 June

  • Fraunhofer Institute for Cell Therapy and Immunology coordinating EU project which aims to shed light on molecular mechanisms of neurodegenerative diseases such as Alzheimer's and Parkinson's

  • World Conference on Regenerative Medicine from October 21–23, 2015 in Leipzig

  • Reliably detecting dengue fever

  • Researchers from Fraunhofer IZI in Halle (Saale) receive funding from the American Alzheimer‘s Association for developing a new model for treatment of Alzheimer's

  • RIBOLUTION Health GmbH founded in Leipzig

  • Dialysis 2.0

  • Latest findings in neuroscience discussed in Leipzig

  • Fraunhofer IZI researcher receives coveted EU Marie Sklodowska-Curie fellowship

  • Fraunhofer algae return from ISS

  • Fraunhofer Institute for Cell Therapy and Immunology IZI and Coburg University of Applied Sciences and Arts join forces in the field of protein biomarker development

  • From tablet to topical gel

  • New procedure for manufacturing safe and effective vaccines

  • How to make hard substrates out of soft ingredients – new research findings could revolutionize stem cell technology

  • Fraunhofer Institute for Cell Therapy and Immunology and Immunic GmbH carry out joint research on new drugs for treating autoimmune diseases

  • Cooperation between Fraunhofer IZI and Lipocalyx GmbH to develop new carrier systems for the genebased treatment of inflammatory diseases

  • Recognising dyslexia in time: Foundations laid for future early test

  • Fraunhofer Institute for Cell Therapy and Immunology sets up research unit at Monash University in Melbourne, Australia

  • Researchers describe novel antibody as potential active agent against Alzheimer's

  • Specialist group Image Analysis of Cell Function successfully evaluated

  • Fraunhofer Institute for Cell Therapy and Immunology launches collaboration with Iovance Biotherapeutics,Inc.

  • Small, smaller, smallest – Leipzig researchers develop new process for surface nanostructuring

  • Fraunhofer Life Science Symposium: Latest Developments in the Field of Infection Diagnostics

  • Chronic Colitis: New Model for Translational Research

  • Sage and bitter apple: plant extracts as active agents for the treatment of chronic inflammatory bowel diseases

  • New Executive Director at Fraunhofer IZI

  • Biomarkers to predict vascular reocclusion following surgery

  • Biomimetic molecules to program cell mechanics

  • McMaster opens $33M Biomedical Engineering and Advanced Manufacturing research centre

  • Andreas Oberbach honored with Hans G Borst Award

  • Faster from the laboratory to the patient: Initiative of Fraunhofer, Helmholtz and Hochschulmedizin promotes pilot project in the health sector

  • Fraunhofer IZI receives grant from TaNeDS research program for new developments in the field of inflammatory bowel disease

  • Good Laboratory Practice (GLP) Test Facility at Fraunhofer IZI Recertified and Expanded

  • Fraunhofer IZI steps up research to improve the treatment of infectious cardiovascular diseases

  • Fighting pathogens with sugar molecules

  • Manufacturing immunotherapeutics for the treatment of brain tumors – preliminary study results published

  • Non-human papillomaviruses as gene shuttle

  • Optimising self-assembling molecular structures for use in diagnostics applications

  • Fraunhofer IZI and Novartis Continue Successful Collaboration with CAR-T Cell Therapy

  • Fraunhofer IZI honors institute founder with symposium

  • New Fraunhofer Project Center "Microelectronic and Optical Systems for Biomedicine" in Erfurt Opens its Doors

  • Pilot Plant for the Industrial-Scale Production of Safe and Effective Vaccines installed at the Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) in Leipzig

  • New Humanized Mouse Models Expected to Offer Greater Insights into Alzheimer’s Disease

  • Fraunhofer Institute for Cell Therapy and Immunology IZI Strengthens Cooperation with Japanese Research and Industry Partners

  • Future of “Molecular Drug Biochemistry and Therapy Development” Project Group Secured at Fraunhofer IZI from 1 January 2019

  • Producing vaccines without the use of chemicals

  • Manufacturing authorization and GMP certificate for antibody production at Fraunhofer IZI

  • Technology for health monitoring of dairy cows successfully licensed out

  • Fraunhofer IZI strengthens contacts to South Korea

  • Saxony's Prime Minister Michael Kretschmer visits Fraunhofer IZI

  • Fraunhofer IZI degree candidate honored with Karl Schügerl Award

  • Fraunhofer IZI to host the Annual Meeting of the German Society for Gene Therapy (DG-GT)

  • Leipzig University’s Faculty of Medicine hands PhD prize to Dr. Alexandra Rockstroh

  • Affordable and mobile purification of dialysis water

  • One year on: Kymriah® CAR-T cell therapy in Germany

  • REANIMA: toward a new paradigm in cardiac regeneration

  • Periodontal disease: Patent for new treatment method

  • Making novel therapeutics safer: Interdisciplinary EU consortium develops innovative model systems for the evaluation of immunomodulating therapeutics

  • Development of therapeutic antibodies for HERV-associated autoimmune and tumor diseases

  • Significant PIONEER milestone

  • Hitchhiker’s Guide to the Cell: Fraunhofer IZI researches to improve imaging methods for organoids

  • Pathogen of Q fever detected in the feces of ticks

  • Development Program for Meprin Protease Inhibitors

  • SaxoCell innovation project in the BMBF competition »Clusters4Future«

  • Professor Ulrich Demuth appointed to the German Ethics Council

  • Patented Fraunhofer IZI technology facilitates specific Dengue virus diagnostics

  • Astacin Proteases Unit established at Fraunhofer IZI

  • Prognostic biomarkers for prostate cancer identified

  • A chemical tailor-made suit for Alzheimer’s drugs

  • Fraunhofer relies on Automation Technologies in Medical Research

  • Fraunhofer IZI cooperates with Nomad Bioscience to develop novel anti-bacterial and anti-viral medications

  • Viromers suitable as carrier systems for gene-based treatment of inflammatory diseases

  • Fraunhofer IZI presents new technologies and services for the healthcare industry at the Fraunhofer Solution Days

  • Rapid diagnostic device for trachoma eye infection delivers first promising result

  • Optimization of novel immune cell therapies

  • SaxoCell – “living drug” Made in Saxony

  • Periodontitis: Researchers search for a new active substance

  • Fraunhofer Prize for Human- and Environment-Centered Technology 2021

  • Researchers aim at developing a vaccine protecting against urinary tract infection

  • Simplified method developed for monitoring CAR T-cell therapies using flow cytometry

  • Anhalt University of Applied Sciences and Fraunhofer IZI open joint research laboratory for natural product-based therapeutics

  • Researchers want to filter and inactivate airborne pathogens using tissue

  • Fraunhofer IZI and Nomad Bioscience extend and broaden collaboration

  • Outstanding bachelor thesis awarded

  • Fraunhofer opens up prospects in structurally weak regions

  • New Fraunhofer Center for Digital Diagnostics

  • Activation of the aryl hydrocarbon receptor (AhR) has an anti-inflammatory effect

  • Fraunhofer Center MEOS becomes technology hub for cell-based therapeutics in Thuringia

  • Fraunhofer IZI and BioNTech to collaborate in the future

  • Preclinical testing of a ATMP for the treatment of knee cartilage damage completed

  • Fraunhofer develops automated production technologies for mRNA-based drugs

  • REMEDi4ALL, an ambitious EU-funded research initiative, launches to drive forward the repurposing of medicines in Europe

  • Roadmap for future production of sufficient product numbers of cell-based cancer drugs

  • International research team elucidates molecular structure of Meprin alpha

  • Fraunhofer IZI implements digital Manufacturing Execution System

  • Hydrogels for tissue engineering

  • Software development expands portfolio of RIBOLUTION Biomarker Center at Fraunhofer IZI

  • GLP test facility of the Fraunhofer IZI certified for test category 2 since January 2023

  • Fraunhofer IZI contributes expertise to Germany's largest collaborative project on mosquito research

  • Symposium on the farewell of Professor Hans-Ulrich Demuth

  • Fraunhofer IZI supports the Czech Republic in establishing a research center for the development of novel cell and gene therapies

  • New strategies in the fight against the widespread disease periodontitis

  • Preclinical and clinical development of a novel CAR-T cell therapy for the treatment of multiple myeloma and clear cell renal cell carcinoma

  • Prof. Dr. Dr. Ulrike Köhl elected to the Saxon Academy of Sciences and Humanities in Leipzig

  • Fraunhofer IZI research project nominated for "HUGO JUNKERS PRIZE for Research and Innovation from Saxony-Anhalt"

  • Development and evaluation of an MRI-guided focused ultrasound system to improve radiation therapy for cancer

  • State government of Mecklenburg-Vorpommern supports research into extracorporeal therapy systems

  • Kick-off for the Central European Advanced Therapy and Immunotherapy Centre (CREATIC)

  • Doctoral scholarship for leukemia cell research

  • Joint appointment with Martin Luther University Halle-Wittenberg

  • Virtual twin to improve treatment with cancer immunotherapies

  • EU project investigates links between land use change, biodiversity loss and zoonosis risk

  • EU project promotes access to ATMPs and its use in clinical practice

  • New approach to early cancer detection honored with Hugo Geiger Prize

  • Fraunhofer IZI expands expertise in the field of cellular immunotherapy with new branch office in Würzburg

  • Biomarkers for the successful treatment of tumors in the bone marrow identified

  • Fraunhofer Institute for Cell Therapy and Immunology wins an award in the Mecklenburg-Vorpommern competition for ideas for the healthcare industry

  • New agent for the treatment of chronic inflammatory bowel diseases

  • National Strategy for Gene- and Cell-Based Therapies

  • Optimizing immunotherapies against malignant melanoma with artificial intelligence

  • Stephan Fricke appointed adjunct professor at Dresden Technical University (TUD)

  • SaxoCell future cluster starts second funding phase

  • QualiBioPharma qualification program honored as cluster success of the year 2024

  • Non-viral vectors for CAR-T cell therapy

• Media Library

Events Expand / Hide

• Conference and meeting rooms

Publications Expand / Hide

• Conventions and conferences

• Teaching activities

• Evaluator activities

• Expert associations

• Publications

• Industry and research partners

• Graduation

• Prizes

• Patents

• Expert associations

• Conventions and conferences

• Industry and research partners

• Teaching activities

• Evaluator activities

• Publications

• Graduation

• Patents

• Association memberships

• Teaching activities

• Industry and research partners

• Graduation

• Conventions and conferences

• Publications

• Patents

• Prizes

Jobs / career Expand / Hide

• What makes us special

• Career starters and professionals

• Pupils and students

• Doctoral program

• Cooperative course

• Vocational training

• FAQ

Contact Expand / Hide

• How to reach us in Leipzig

• How to reach us in Potsdam-Golm

• How to reach us in Halle (Saale)

• How to reach us in Rostock

• Research management

• Business Development (Diagnostics / ZDD) and Patent Management